Nuveen »

Aktis Oncology shares owned by Nuveen

Quarter-by-quarter ownership of Aktis Oncology shares owned by Nuveen from 13F filings

Historical chart of Nuveen investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Nuveen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Nuveen

Quarter filed Position value Share count Share price at filing
2026-03-31 $438k 25k 17.89

More positions owned by Nuveen

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Exxon Mobil Corporation (XOM)
Nushares Etf Tr Nuveen Internati (NXUS)
Costco Wholesale Corporation (COST)

View all positions for Nuveen

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
BlackRock
RA Capital Management
Henderson Group
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
Geode Capital Management
Avidity Partners Management
AH Capital Management
UBS Group
Arrowpoint Asset Management
Alyeska Investment Group

View all funds holding Aktis Oncology